Literature DB >> 22514347

Differential impact of interferon regulatory factor 7 in initiation of the type I interferon response in the lymphocytic choriomeningitis virus-infected central nervous system versus the periphery.

Jeanette Erbo Christensen1, Christina Fenger, Shohreh Issazadeh-Navikas, Anna Krug, Peter Liljestrøm, Stanislas Goriely, Søren Riis Paludan, Bente Finsen, Jan Pravsgaard Christensen, Allan Randrup Thomsen.   

Abstract

Interferon (IFN) regulatory factors (IRFs) are a family of transcription factors involved in regulating type I IFN genes and other genes participating in the early antiviral host response. To better understand the mechanisms involved in virus-induced central nervous system (CNS) inflammation, we studied the influence of IRF1, -3, -7, and -9 on the transcriptional activity of key genes encoding antiviral host factors in the CNS of mice infected with lymphocytic choriomeningitis virus (LCMV). A key finding is that neither IRF3 nor IRF7 is absolutely required for induction of a type I IFN response in the LCMV-infected CNS, whereas concurrent elimination of both factors markedly reduces the virus-induced host response. This is unlike the situation in the periphery, where deficiency of IRF7 almost eliminates the LCMV-induced production of the type I IFNs. This difference is seemingly related to the local environment, as peripheral production of type I IFNs is severely reduced in intracerebrally (i.c.) infected IRF7-deficient mice, which undergo a combined infection of the CNS and peripheral organs, such as spleen and lymph nodes. Interestingly, despite the redundancy of IRF7 in initiating the type I IFN response in the CNS, the response is not abolished in IFN-β-deficient mice, as might have been expected. Collectively, these data demonstrate that the early type I IFN response to LCMV infection in the CNS is controlled by a concerted action of IRF3 and -7. Consequently this work provides strong evidence for differential regulation of the type I IFN response in the CNS versus the periphery during viral infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22514347      PMCID: PMC3416342          DOI: 10.1128/JVI.07090-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  Innate immune recognition of viral infection.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2006-02       Impact factor: 25.606

Review 2.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

Review 3.  Type I interferons in host defense.

Authors:  Daniel B Stetson; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

4.  Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis.

Authors:  V C Asensio; I L Campbell
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 5.  Innate recognition of intracellular pathogens: detection and activation of the first line of defense.

Authors:  Simon B Rasmussen; Line S Reinert; Søren R Paludan
Journal:  APMIS       Date:  2009-05       Impact factor: 3.205

6.  Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells.

Authors:  A G Hovanessian; R E Brown; I M Kerr
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

7.  Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection.

Authors:  Shalina S Ousman; Jianping Wang; Iain L Campbell
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.

Authors:  M Sato; N Hata; M Asagiri; T Nakaya; T Taniguchi; N Tanaka
Journal:  FEBS Lett       Date:  1998-12-11       Impact factor: 4.124

9.  Immunological unresponsiveness of nude mice to LCM virus infection.

Authors:  P J Christoffersen; M Volkert; J Rygaard
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-12

10.  Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice.

Authors:  D H Gilden; G A Cole; A A Monjan; N Nathanson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  7 in total

1.  IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.

Authors:  Wen Li; Markus J Hofer; So Ri Jung; Sue-Ling Lim; Iain L Campbell
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

2.  Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  Shenghua Zhou; Anna M Cerny; Katherine A Fitzgerald; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

Review 3.  Innate immune interactions within the central nervous system modulate pathogenesis of viral infections.

Authors:  Sharmila Nair; Michael S Diamond
Journal:  Curr Opin Immunol       Date:  2015-07-08       Impact factor: 7.486

4.  Differentiation of neurons restricts Arbovirus replication and increases expression of the alpha isoform of IRF-7.

Authors:  Kimberly L W Schultz; Patty S Vernon; Diane E Griffin
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

5.  Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging.

Authors:  Aisling A Murphy; Pamela C Rosato; Zachary M Parker; Alexey Khalenkov; David A Leib
Journal:  Virology       Date:  2013-06-16       Impact factor: 3.616

Review 6.  Complexities of Type I Interferon Biology: Lessons from LCMV.

Authors:  Tamara Suprunenko; Markus J Hofer
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

7.  Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.

Authors:  Franz J Zemp; Brienne A McKenzie; Xueqing Lun; Lori Maxwell; Karlyne M Reilly; Grant McFadden; V Wee Yong; Peter A Forsyth
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.